TITLE

Home monitoring reduces inappropriate ICD shocks by 52%

PUB. DATE
February 2013
SOURCE
British Journal of Hospital Medicine (17508460);Feb2013, Vol. 74 Issue 2, p70
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports Biotronik, has published the clinical results of the trial Effectiveness and Cost of ICD Follow-Up Schedule with Telecardiology (ECOST), which states that home monitoring reduces inappropriate implantable cardioverter-defibrillators (ICD) shocks by 52 percent.
ACCESSION #
86145749

 

Related Articles

  • Nearly one-fourth of ICD implants failed to meet implantation criteria. Ellis, Brian // Cardiology Today;Feb2011, Vol. 14 Issue 2, p1 

    The article discusses a study which found out that non-evidence based implantation of an implantable cardioverter defibrillator (ICD) could increase the risk of in-hospital death and post-procedural complications.

  • Update on implantable cardioverter-defibrillators. Sadovsky, Richard // American Family Physician;2/15/1997, Vol. 55 Issue 3, p936 

    Focuses on a study by A. Raviele, published in a 1996 edition of the `American Journal of Cardiology,' which highlighted the implantation of cardioverter-defibrillators in the treatment of survivors of cardiac arrest who failed to respond adequately to pharmacologic and surgical interventions....

  • HRS notebook.  // Medical Device Daily;5/13/2013, Vol. 17 Issue 92, p5 

    The article reports that medical device manufacturer Sorin Group will launch its Smartview remote monitoring solution for patients with implanted cardiac rhythm management (CRM) devices.

  • Cardiac Devices May Benefit Healthier Heart Patients.  // Heart Advisor;Oct2014, Vol. 17 Issue 10, p9 

    The article reports on a study which suggests that patients with less severe heart impairment are more likely to have better survival times with implantable cardioverter defibrillators (ICDs) than their counterparts.

  • Disclosure and performance: expecting more, and better.  // CMAJ: Canadian Medical Association Journal;8/30/2005, Vol. 173 Issue 5, p457 

    Deals with the failures associated with the disclosure of information in medical care in Canada. Potential of an implantable cardioverter defibrillator to malfunction; Consequences of mismanaging patient care; Attempts made to monitor practice for patients with specified conditions.

  • GUEST EDITORIAL. Nursing care in the 21st century: embracing technology. Shuldham, Caroline // British Journal of Cardiac Nursing;Dec2014, Vol. 9 Issue 12, p578 

    The author observes that introduction of technology can be met with resistance or fear by nurses and can require them to rethink the way they work by designing changes to services and roles. Topics discussed include the benefits technology can bring to patients' care, and The Integrated Digital...

  • RESYNCHRONIZATION THERAPY IN PATIENTS WITH HEART FAILURE. Kostić, Tomislav; Perišić, Zoran; Koraćević, Goran; Stanojević, Dragana; Milić, Dragan; Mitov, Vladimir; Pavlović, Milan; Šalinger Martinović, Sonja; Todorović, Lazar; Ćirić Zdravković, Snežana; Golubović, Mladjan // Acta Medica Medianae;Jun2013, Vol. 52 Issue 2, p10 

    Prognosis in heart failure (HF) is poor and mortality widely ranges - 15-60% per year. Cardiac resynchronization therapy (CRT) is a therapeutic concept for patients who have NYHA III or IV class, LVEF ≤ 35%, left bundle branch block with wide QRS ≥ 120ms and ventricular dyssynchrony...

  • Study: ICD found effective in 'primary prevention' of heart disease.  // Cardiovascular Device Update;May2007, Vol. 13 Issue 5, p22 

    The article reports on the results of a study conducted by researchers at the University of Pennsylvania School of Medicine on the effectiveness of implantable cardioverter-defibrillators (ICD) in preventing heart disease. The study found that most patients with ICD enjoy a quality of life...

  • On Deactivating Pacemakers and ICDs. Klein, Ryan // Ethics & Medics;Nov2014, Vol. 39 Issue 11, p1 

    The article focuses on the ethical dilemma faced by people with pacemakers and implantable cardioverter defibrillators (ICD) regarding their deactivation and removal. Topics discussed include rejecting life-prolonging procedures that are insufficiently beneficial or excessively burdensome...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics